Spanish Priest Dies of Ebola; UN Debates Ethics

Tuesday, 12 Aug 2014 08:46 AM

 

  Comment  |
   Contact  |
  Print  
|  A   A  
  Copy Shortlink

MADRID — A Spanish missionary priest being treated for Ebola died Tuesday in a Madrid hospital amid a worldwide debate over who should get experimental Ebola treatments.

After a meeting with medical experts, the World Health Organization declared it is ethical to use unproven Ebola drugs and vaccines in the current outbreak in West Africa provided the right conditions are met. Its statement, however, sidestepped the key questions of who should get the limited drugs and how that should be decided.

Two more experimental Ebola treatments were reportedly heading Tuesday to Liberia to be used on two infected doctors — the first Africans to receive the untested drug.

The U.N. health agency says 1,013 people have died so far in the Ebola outbreak in West Africa and authorities have recorded 1,848 suspected or confirmed cases. The killer virus, spread by direct contact with bodily fluids like blood, diarrhea and vomit, was detected in Guinea in March and has since spread to Sierra Leone, Liberia and possibly Nigeria.

Two Americans and reportedly the Spanish priest who died had gotten an experimental Ebola treatment never tested in humans. But the vast majority of Ebola victims have been Africans, and some have protested that their citizens are not getting access to the novel drugs.

"We can't afford to be passive while many more die," said Aisha Dab, a Senegalese-Gambian journalist who was tweeting using the hashtag "GiveUsTheSerum." ''That's why we raise our voice for the world to hear us."

The Spanish missionary, 75-year-old Miguel Parajes, died in Madrid's Carlos III Hospital, the hospital and his order said. The hospital would not confirm that he had been treated with the drug, but his order and Spain's Health Ministry said earlier that he would be. His body will be cremated Wednesday to avoid any further public health risks, the hospital said.

Parajes had worked for the San Juan de Dios hospital order, a Spain-based Catholic humanitarian group, and had been helping to treat people with Ebola in Liberia when he became ill and was evacuated.

WHO decided it is ethical to use experimental treatments and vaccines in an ongoing outbreak even though there's no evidence yet that these experimental drugs can actually help fight Ebola — and it is possible they could be harmful. Still, this outbreak has had about a 50 percent death rate, according to the U.N., adding urgency to the search for a treatment.

"In the particular circumstances of this outbreak and provided certain conditions are met, the panel reached consensus that it is ethical to offer unproven interventions with as yet unknown efficacy and adverse effects, as potential treatment or prevention," the agency said.

The panel said "more detailed analysis and discussion" are needed to decide how to achieve fair distribution in communities and among countries, since there is an extremely limited supply of the experimental drugs and vaccines.

WHO also said the world had "a moral duty" to properly collect evidence about the untested treatment's safety and effectiveness in a proper scientific trial.

West African nations are struggling to control both the deadly outbreak and the fear it has engendered. Most airlines flying in and out of the Liberian capital of Monrovia have suspended flights amid the unprecedented health crisis.

The Ivory Coast, which shares borders with Liberia and Guinea, banned direct flights from those countries and said it would increase health inspections at its borders.

Liberian President Ellen Johnson Sirleaf suspended all travel by executive branch officials for one month on Tuesday. She also ordered those already abroad to return home within a week "or be considered as abandoning their jobs," according to a statement.

A U.K.-based public relations firm representing Liberia said the experimental Ebola treatment would be arriving within the next 48 hours to treat the two Liberian physicians.

"The two doctors gave their consent, themselves being medical professionals, for the drug to be administered," the statement said. "The drugmaker has agreed to supply a sufficient amount of this drug only for these two patients."

Turkey's health ministry, meanwhile, said a passenger from Nigeria was hospitalized Tuesday after arriving at Istanbul airport with a high fever. It said medical workers did not know if she had Ebola but were taking precautions. The Turkish Airlines plane, which was supposed to travel onto Barcelona, was being disinfected.

© Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

  Comment  |
   Contact  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Blasts, Gunfire in Kabul After Suicide Bomber Hits UK Embassy Car

Thursday, 27 Nov 2014 07:49 AM

Gunfire and explosions rocked Kabul Thursday as Taliban militants attacked a central district that houses several embass . . .

Mexico Plans Police, Govt Reforms in Wake of Student Deaths

Thursday, 27 Nov 2014 13:01 PM

Mexico's President Enrique Pena Nieto is set to unveil a plan to combat corruption in a bid to contain a crisis over the . . .

Pope Condemns Islamic State Violence

Thursday, 27 Nov 2014 12:33 PM

On the eve of a trip to the Middle East, Pope Francis is urging religious and political leaders to speak out against att . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved